BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37481855)

  • 1. Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.
    Heabah NAE; Darwish SA; Eid AM
    Pathol Res Pract; 2023 Aug; 248():154703. PubMed ID: 37481855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.
    Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y
    Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
    Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
    Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ROR1 has prognostic significance in triple negative breast cancer.
    Chien HP; Ueng SH; Chen SC; Chang YS; Lin YC; Lo YF; Chang HK; Chuang WY; Huang YT; Cheung YC; Shen SC; Hsueh C
    Virchows Arch; 2016 May; 468(5):589-95. PubMed ID: 26874851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
    Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375.
    Xu N; Qiao L; Yin L; Li H
    J BUON; 2019; 24(6):2273-2279. PubMed ID: 31983094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
    Cao J; Wang X; Dai T; Wu Y; Zhang M; Cao R; Zhang R; Wang G; Jiang R; Zhou BP; Shi J; Kang T
    Theranostics; 2018; 8(10):2739-2751. PubMed ID: 29774072
    [No Abstract]   [Full Text] [Related]  

  • 10. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
    Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and clinical significance of ROR1 in lung adenocarcinoma.
    Schiavone G; Epistolio S; Martin V; Molinari F; Barizzi J; Mazzucchelli L; Frattini M; Wannesson L
    BMC Cancer; 2020 Nov; 20(1):1085. PubMed ID: 33172431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells.
    Lee KJ; Kim NH; Kim HS; Kim Y; Lee JJ; Kim JH; Cho HY; Jeong SY; Park ST
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241228
    [No Abstract]   [Full Text] [Related]  

  • 13. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
    Nema R; Patel P; Kumar A
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ROR1 inhibits epithelial to mesenchymal transition in human lung adenocarcinoma via mTOR signaling pathway.
    Long MP; Wang HL; Luo YB; Yang JH
    Int J Clin Exp Pathol; 2018; 11(10):4759-4770. PubMed ID: 31949551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma.
    Ida L; Yamaguchi T; Yanagisawa K; Kajino T; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2016 Feb; 107(2):155-61. PubMed ID: 26661061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROR1 and ROR2 expression in pancreatic cancer.
    Liu D; Sharbeen G; Phillips P; ; Ford CE
    BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
    Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
    Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
    Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
    Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma.
    Khaledian B; Taguchi A; Shin-Ya K; Kondo-Ida L; Kagaya N; Suzuki M; Kajino T; Yamaguchi T; Shimada Y; Takahashi T
    Cancer Sci; 2021 Mar; 112(3):1225-1234. PubMed ID: 33370472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.